2026 Recipients


Antonia Susnjar


Photo of Antonia Susnjar.

Antonia Susnjar | Biomedical Engineering

Director of Research and Scientific Affairs, GE Healthcare

There is a central focus predominant in Antonia Susnjar’s education, research and work: developing and applying imaging techniques that translate complex physiological processes into quantified biomarkers that clinicians can use to guide treatment decisions. In her current role as director of research and scientific affairs at GE Healthcare, she leads strategic research partnerships with academic institutions, helping investigators align innovative scientific ideas with real-world clinical needs and technology roadmaps. Her efforts help accelerate the clinical adoption of emerging imaging technologies and create value for patients and customers. Among her collaborators are the Cleveland Clinic, Cincinnati Children’s Hospital and IU School of Medicine.

In her postdoctoral fellowship at Harvard Medical School, Susnjar pioneered novel PET tracer applications for pulmonary fibrosis and developed breakthrough motion correction techniques for lung transplant imaging. Concurrently, she worked as a magnetic resonance spectroscopy (MRS) scientist at BrainSpec, authoring a grant proposal for the Alzheimer’s Drug Discovery Foundation that yielded a $600,000 award, and preparing Small Business Innovation Research grant applications focused on using MRS to detect pseudo-progression in gliomas.

Susnjar, who has contributed to the submission of $6 million+ in research funding, prioritizes illnesses whose early or subtle changes are critical but difficult to detect with current gold-standard approaches. Her contributions have resulted in 20 peer-reviewed publications outlining her studies of hundreds of research participants spanning challenging and clinically important groups such as patients with idiopathic pulmonary fibrosis, veterans with traumatic brain injury or post-traumatic stress disorder and individuals at risk for neurodegenerative disease. She is grateful to Purdue for providing “access to outstanding imaging equipment and exposure to a truly unique research environment that emphasized collaboration and real-world impact.”